Journal of Nutrition LabDiet, Your World of Nutritional Answers

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Baulny, H. O.
Right arrow Articles by de Parscau, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Baulny, H. O.
Right arrow Articles by de Parscau, L.
© 2007 American Society for Nutrition J. Nutr. 137:1561S-1563S, June 2007


Supplement: Aromatic Amino Acids and Related Substances: Chemistry, Biology, Medicine, and Application: SESSION 3

Management of Phenylketonuria and Hyperphenylalaninemia1,2

Hélène Ogier de Baulny3,*, Véronique Abadie4, François Feillet5 and Loïc de Parscau6

3 Service de Neurologie et Maladies Métaboliques, Hôpital R. Debré, Assistance Publique des Hôpitaux de Paris, 75019 Paris, France; 4 Fédération de Pédiatrie, Hôpital Necker-Enfants-Malades, Assistance Publique des Hôpitaux de Paris, 75015 Paris, France; 5 Service de Médecine Infantile, Hôpital d'enfants, 54511 Vandoeuvre, France; and 6 Département de Pédiatrie et Génétique Médicale, CHU de Morvan, 29609 Brest, France

* To whom correspondence should be addressed. E-mail: helene.ogier{at}rdb.aphp.fr.

Hyperphenylalaninemia (HPA) is the most frequently inherited disorder of amino acid metabolism (prevalence 1:10,000). In France, a nationwide neonatal screening was organized in 1978 to control its efficacy and patient follow-up. Phenylketonuria (PKU) was diagnosed in 81.6% of screened patients, the remaining affected with either non-PKU HPA (17.2%) or with cofactor deficiency (1.1%). French guidelines were established to specify the minimal diagnosis procedures and optimal treatment of patients. A low-phenylalanine diet must be started within the first days of life for all newborns whose blood phenylalanine levels are above 10 mg/dL (600 µmol/L). The dietary control must keep the phenylalanine levels between 2 and 5 mg/dL (120 and 300 µmol/L) until 10 y of age. Thereafter, a progressive and controlled relaxation of the diet is allowed, keeping levels below 15 mg/dL until the end of adolescence and below 20 mg/dL (1200 µmol/L) in adulthood. A lifelong follow-up is recommended for PKU women to prevent for maternal PKU.





This article has been cited by other articles:


Home page
J. Nutr.Home page
K. Takai
Introduction to the Transdisciplinary International Conference on Aromatic Amino Acids and Related Substances: Chemistry, Biology, Medicine, and Application
J. Nutr., June 1, 2007; 137(6): 1501S - 1503S.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2007 by American Society for Nutrition